Combined Results of Two Cross-Sectional Surveys on the Participation in Clinical Trials and the e-Consent Procedure in the Landscape of Haematology.

clinical trial barriers clinical trial enrolment clinical trials e-consent patient-reported outcome physician-reported outcome

Journal

Clinics and practice
ISSN: 2039-7275
Titre abrégé: Clin Pract
Pays: Switzerland
ID NLM: 101563282

Informations de publication

Date de publication:
23 Nov 2023
Historique:
received: 26 09 2023
revised: 07 11 2023
accepted: 22 11 2023
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 22 12 2023
Statut: epublish

Résumé

Despite the motivation of oncology patients to take part in clinical trials, only a minority of them are enrolled in clinical trials. Implementation of new practical procedures can become a barrier that withholds patients from participating in clinical trials. Treating physicians are crucial in augmenting trial accrual. The drivers that promote physicians to allocate patients for clinical trials need further assessment. We conducted two separate cross-sectional surveys, addressing patients with a haematological disease in one survey and haematologists in another survey. The patient survey was filled out by 420 patients. Significant relationships between the willingness to participate in a trial and trial knowledge (

Identifiants

pubmed: 38131682
pii: clinpract13060133
doi: 10.3390/clinpract13060133
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1520-1531

Subventions

Organisme : Novartis (Belgium)
ID : ON410REV

Auteurs

Bert Heyrman (B)

Ziekenhuis Netwerk Antwerpen, Department of Haematology, 2020 Antwerp, Belgium.

Stef Meers (S)

Algemeen Ziekenhuis KLINA, Department of Haematology, 2930 Brasschaat, Belgium.

Ann Van De Velde (A)

Department of Haematology, University Hospital Antwerp, 2650 Edegem, Belgium.

Sébastien Anguille (S)

Department of Haematology, University Hospital Antwerp, 2650 Edegem, Belgium.

Classifications MeSH